Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jul;64(1):35–40. doi: 10.1038/bjc.1991.235

Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy.

G Gallagher 1, F al-Azzawi 1, L P Walsh 1, G Wilson 1, J Handley 1
PMCID: PMC1977296  PMID: 1713052

Abstract

We have defined a novel ovarian cancer-associated membrane antigen, 14C1, using human monoclonal antibodies derived by EBV-transformation of in situ sensitised patients' B-cells. The pattern of recognition of this antigen by these antibodies suggests that at least three epitopes are discernable. These antibodies can be used to promote the in vitro killing of ovarian cancer cells by activated macrophages and cytokines, implying a role for this antigen in the immunotherapy of ovarian malignancies. Evidence is presented that the 14C1 antigen may have some transmembrane signalling function.

Full text

PDF
35

Images in this article

37Figure 1
on p.37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hall T., Steplewski Z., Koprowski H. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3506–3510. doi: 10.1073/pnas.81.11.3506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al-Azzawi F., Stimson W. H., Govan A. D. Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. J Clin Lab Immunol. 1987 Feb;22(2):71–75. [PubMed] [Google Scholar]
  3. Balkwill F. R., Ward B. G., Moodie E., Fiers W. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer. Cancer Res. 1987 Sep 15;47(18):4755–4758. [PubMed] [Google Scholar]
  4. Cannistra S. A., Rambaldi A., Spriggs D. R., Herrmann F., Kufe D., Griffin J. D. Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest. 1987 Jun;79(6):1720–1728. doi: 10.1172/JCI113012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crawford R. M., Finbloom D. S., Ohara J., Paul W. E., Meltzer M. S. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol. 1987 Jul 1;139(1):135–141. [PubMed] [Google Scholar]
  6. Decker T., Lohmann-Matthes M. L., Gifford G. E. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J Immunol. 1987 Feb 1;138(3):957–962. [PubMed] [Google Scholar]
  7. Ey P. L., Ashman L. K. The use of alkaline phosphatase-conjugated anti-immunoglobulin with immunoblots for determining the specificity of monoclonal antibodies to protein mixtures. Methods Enzymol. 1986;121:497–509. doi: 10.1016/0076-6879(86)21050-2. [DOI] [PubMed] [Google Scholar]
  8. Feinman R., Henriksen-DeStefano D., Tsujimoto M., Vilcek J. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol. 1987 Jan 15;138(2):635–640. [PubMed] [Google Scholar]
  9. Gallagher G., al-Azzawi F., Davis J., Stimson W. H. Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro. Br J Cancer. 1989 Jun;59(6):919–921. doi: 10.1038/bjc.1989.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gallagher G., al-Azzawi F., Walsh L. P., Wilson G. 14C1, an antigen associated with human ovarian cancer, defined using a human IgG monoclonal antibody. Clin Exp Immunol. 1991 Jan;83(1):92–95. doi: 10.1111/j.1365-2249.1991.tb05594.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grabstein K. H., Urdal D. L., Tushinski R. J., Mochizuki D. Y., Price V. L., Cantrell M. A., Gillis S., Conlon P. J. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science. 1986 Apr 25;232(4749):506–508. doi: 10.1126/science.3083507. [DOI] [PubMed] [Google Scholar]
  12. Haspel M. V., McCabe R. P., Pomato N., Janesch N. J., Knowlton J. V., Peters L. C., Hoover H. C., Jr, Hanna M. G., Jr Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Cancer Res. 1985 Aug;45(8):3951–3961. [PubMed] [Google Scholar]
  13. Johnson W. J., Adams D. O. Assays detecting the antibody-dependent and independent binding and cytolysis of tumor cells by murine macrophages. Methods Enzymol. 1986;132:555–568. doi: 10.1016/s0076-6879(86)32041-x. [DOI] [PubMed] [Google Scholar]
  14. Kan-Mitchell J., Imam A., Kempf R. A., Taylor C. R., Mitchell M. S. Human monoclonal antibodies directed against melanoma tumor-associated antigens. Cancer Res. 1986 May;46(5):2490–2496. [PubMed] [Google Scholar]
  15. Kjeldsen T. B., Rasmussen B. B., Rose C., Zeuthen J. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Cancer Res. 1988 Jun 1;48(11):3208–3214. [PubMed] [Google Scholar]
  16. Lubeck M. D., Kimoto Y., Steplewski Z., Koprowski H. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies. Cell Immunol. 1988 Jan;111(1):107–117. doi: 10.1016/0008-8749(88)90055-x. [DOI] [PubMed] [Google Scholar]
  17. Malkovský M., Loveland B., North M., Asherson G. L., Gao L., Ward P., Fiers W. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature. 1987 Jan 15;325(6101):262–265. doi: 10.1038/325262a0. [DOI] [PubMed] [Google Scholar]
  18. Mattes M. J., Look K., Furukawa K., Pierce V. K., Old L. J., Lewis J. L., Jr, Lloyd K. O. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res. 1987 Dec 15;47(24 Pt 1):6741–6750. [PubMed] [Google Scholar]
  19. Nathan C. F., Prendergast T. J., Wiebe M. E., Stanley E. R., Platzer E., Remold H. G., Welte K., Rubin B. Y., Murray H. W. Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med. 1984 Aug 1;160(2):600–605. doi: 10.1084/jem.160.2.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Neale M. L., Fiera R. A., Matthews N. Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer. 1990 Jan 15;45(1):203–208. doi: 10.1002/ijc.2910450136. [DOI] [PubMed] [Google Scholar]
  21. Pimm M. V., Perkins A. C., Armitage N. C., Baldwin R. W. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med. 1985 Sep;26(9):1011–1023. [PubMed] [Google Scholar]
  22. Sakakibara K., Ueda R., Ohta M., Nakashima N., Tomoda Y., Takahashi T. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Cancer Res. 1988 Aug 15;48(16):4639–4645. [PubMed] [Google Scholar]
  23. Sekine H., Hayes D. F., Ohno T., Keefe K. A., Schaetzl E., Bast R. C., Knapp R., Kufe D. W. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. J Clin Oncol. 1985 Oct;3(10):1355–1363. doi: 10.1200/JCO.1985.3.10.1355. [DOI] [PubMed] [Google Scholar]
  24. Stevenson H. C., Keenan A. M., Woodhouse C., Ottow R. T., Miller P., Steller E. P., Foon K. A., Abrams P. G., Beman J., Larson S. M. Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis. Cancer Res. 1987 Nov 15;47(22):6100–6103. [PubMed] [Google Scholar]
  25. Ward B. G., Wallace K. Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts. Cancer Res. 1987 Sep 1;47(17):4714–4718. [PubMed] [Google Scholar]
  26. Ward B., Mather S., Shepherd J., Crowther M., Hawkins L., Britton K., Slevin M. L. The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy. Br J Cancer. 1988 Nov;58(5):658–662. doi: 10.1038/bjc.1988.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ziegler-Heitbrock H. W., Möller A., Linke R. P., Haas J. G., Rieber E. P., Riethmüller G. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res. 1986 Nov;46(11):5947–5952. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES